Test method for evaluating arrhythmia caused by action of medicament on human nether-a-gogo related gene (hERG)

A test method and arrhythmia technology, applied in measuring devices, material analysis through electromagnetic means, instruments, etc., can solve problems such as poor TdP correlation, high TdP false positive rate, loss of pharmaceutical companies, etc.

Inactive Publication Date: 2011-11-23
上海灏远生物医药科技有限公司
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, further studies found that hERG ion channel blockade was poorly correlated with induced TdP in clinical

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Test method for evaluating arrhythmia caused by action of medicament on human nether-a-gogo related gene (hERG)
  • Test method for evaluating arrhythmia caused by action of medicament on human nether-a-gogo related gene (hERG)
  • Test method for evaluating arrhythmia caused by action of medicament on human nether-a-gogo related gene (hERG)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] The present invention is further described below in conjunction with the examples.

[0021] The test method proposed by the present invention for assessing the arrhythmia caused by the action of drugs on hERG is a more comprehensive and more accurate innovative solution to the methods commonly used in the world at present. The test method includes an in vitro cell model channel Analysis, isolated heart tissue detection and organ level / whole animal three processes, characterized in that: the channel analysis of the extracellular cell model takes the following steps:

[0022] 1) Depolarize the cell to 40mv / 5ms to activate the hERG ion channel according to the routine, and then clamp the cell back to -50mv / s to record the inactivation process of the channel. The maximum current recorded at -50mv is the one to be recorded hERG channel current amplitude;

[0023] 2) Perform a voltage clamp test to obtain the speed at which the drug leaves the channel; this test includes two...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a test method for evaluating arrhythmia caused by action of medicament on a human nether-a-gogo related gene (hERG). The test method is characterized by comprising the following steps of: depolarizing cells to 40 mv/5ms conventionally to activate an hERG ion channel; returning thin pliers to -50 mv/s to record the deactivating process of the channel, wherein the maximum current recorded at -50 mv is the hERG ion channel current amplitude required to be recorded; performing a voltage clamp flow test to acquire the speed of the medicament separated from the channel; calculating the time dependence of the compound hERG ion channel at 500 ms and 2 s by inhibition concentration 50150 (IC50150) ms/IC50500ms and IC50150ms/IC502s, wherein if the ratio is high, the time dependence is high; and on the premise of determining that the medicament has remarkable time dependence in the blocking hERG ion channel test, calculating the recovery time index of the medicament hERG blocking agent by a formula of RRec equal to (IC150ms-2-IC502s)/IC150150ms-IC502s), wherein the medicament with the recovery time index of less than 25 is determined to have higher possibility of inducing TdP.

Description

technical field [0001] The invention relates to an important drug safety evaluation technology, and is a new test method for evaluating the arrhythmia caused by the effect of drugs on hERG. Background technique [0002] The preclinical cardiac safety assessment of new drugs is of great significance when it comes to patient safety. Since 2005, G7 developed countries have begun to implement the cardiac safety regulations jointly formulated by drug regulatory agencies and large pharmaceutical companies in the European Union, Japan, and the United States. Assessed S7B regulations, the benefits are huge. The preclinical cardiac safety assessment of drugs has greatly reduced the side effects of new drugs on the heart, saving European and American pharmaceutical companies more than 15 billion US dollars in research and development costs each year. Over time, the S7B regulations will gradually be accepted by drug regulators and pharmaceutical companies in various countries. [000...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N27/00
Inventor 张之颢
Owner 上海灏远生物医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap